These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 22591196)

  • 21. Studies of chitosan/organic acid/Eudragit RS/RL-coated system for colonic delivery.
    Kaur K; Kim K
    Int J Pharm; 2009 Jan; 366(1-2):140-8. PubMed ID: 18835342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Achieving gastroresistance without coating: Formulation of capsule shells from enteric polymers.
    Barbosa JAC; Al-Kauraishi MM; Smith AM; Conway BR; Merchant HA
    Eur J Pharm Biopharm; 2019 Nov; 144():174-179. PubMed ID: 31541663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and in vitro dissolution profile of dual polymer (Eudragit RS100 and RL100) microparticles of diltiazem hydrochloride.
    Das SK; Das NG
    J Microencapsul; 1998; 15(4):445-52. PubMed ID: 9651866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a novel tablet-in-capsule formulation of mesalamine for inflammatory bowel disease.
    Patel MM; Amin AF
    Pharm Dev Technol; 2013; 18(2):390-400. PubMed ID: 22304735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colon-targeted celecoxib-loaded Eudragit® S100-coated poly-ε-caprolactone microparticles: preparation, characterization and in vivo evaluation in rats.
    Ghorab DM; Amin MM; Khowessah OM; Tadros MI
    Drug Deliv; 2011; 18(7):523-35. PubMed ID: 21793779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colonic release and reduced intestinal tissue damage of coated tablets containing naproxen inclusion complex.
    Piao ZZ; Lee MK; Lee BJ
    Int J Pharm; 2008 Feb; 350(1-2):205-11. PubMed ID: 17928177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlled release microspheres based on Eudragit L100 for the oral administration of erythromycin.
    Morishita I; Morishita M; Machida Y; Nagai T
    Drug Des Deliv; 1991 Jul; 7(4):309-19. PubMed ID: 1930622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
    Maghsoodi M; Sadeghpoor F
    Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and tabletting of dipyridamole alginate-Eudragit microspheres.
    Gürsoy A; Kalkan F; Okar I
    J Microencapsul; 1998; 15(5):621-8. PubMed ID: 9743917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and in vitro dissolution profile of zidovudine loaded microspheres made of Eudragit RS 100, RL 100 and their combinations.
    Nath B; Nath LK; Kumar P
    Acta Pol Pharm; 2011; 68(3):409-15. PubMed ID: 21648196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. pH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheres.
    Quan JS; Jiang HL; Kim EM; Jeong HJ; Choi YJ; Guo DD; Yoo MK; Lee HG; Cho CS
    Int J Pharm; 2008 Jul; 359(1-2):205-10. PubMed ID: 18490120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biodegradable anionic acrylic resin based hollow microspheres of moderately water soluble drug rosiglitazone maleate: preparation and in vitro characterization.
    Rane BR; Gujarathi NA; Patel JK
    Drug Dev Ind Pharm; 2012 Dec; 38(12):1460-9. PubMed ID: 22356275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The robustness and flexibility of an emulsion solvent evaporation method to prepare pH-responsive microparticles.
    Nilkumhang S; Basit AW
    Int J Pharm; 2009 Jul; 377(1-2):135-41. PubMed ID: 19515519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pH-dependent colon-targeted oral drug delivery system using methacrylic acid copolymers. II. Manipulation of drug release using Eudragit L100 and Eudragit S100 combinations.
    Khan MZ; Stedul HP; Kurjaković N
    Drug Dev Ind Pharm; 2000 May; 26(5):549-54. PubMed ID: 10789067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative pharmaceutical study on colon targeted micro-particles of celecoxib: in-vitro-in-vivo evaluation.
    Bazan L; Bendas ER; El Gazayerly ON; Badawy SS
    Drug Deliv; 2016 Nov; 23(9):3339-3349. PubMed ID: 27086898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract.
    Liu F; Moreno P; Basit AW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):311-5. PubMed ID: 19932177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and release characteristics of polymer-coated and blended alginate microspheres.
    Lee DW; Hwang SJ; Park JB; Park HJ
    J Microencapsul; 2003; 20(2):179-92. PubMed ID: 12554373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.
    Bando H; McGinity JW
    Int J Pharm; 2006 Oct; 323(1-2):11-7. PubMed ID: 16815652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibiting the gastric burst release of drugs from enteric microparticles: the influence of drug molecular mass and solubility.
    Alhnan MA; Cosi D; Murdan S; Basit AW
    J Pharm Sci; 2010 Nov; 99(11):4576-83. PubMed ID: 20845456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methacrylate micro/nano particles prepared by spray drying: a preliminary in vitro/in vivo study.
    Muñoz Ortega B; Sallam MA; Marín Boscá MT
    Drug Deliv; 2016 Sep; 23(7):2439-2444. PubMed ID: 25715809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.